Breaking

Israeli military detains 6 settlers after attack on forces in occupied West Bank
Big crowds gather in Hungarian capital to defy ban on Budapest Pride
Bezos wedding protesters demand the billionaire ‘get out of our lagoon’
How Qatar defused Iran’s attack on the largest US-run base in the region
Police clash with anti-government protesters calling for early elections in Serbia
Breakdown of NVDA’s Stock Price and S&P 500: Actionable Technical Insights
Week Ahead: As NIFTY Breaks Out, Change Of Leadership Likely To Keep The Index Moving
Editor’s Picks: Platinum Hits 11 Year High, Expert Touts Silver’s Bullish Future

Business
World News
Investing
Stocks
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Editor’s Picks: Platinum Hits 11 Year High, Expert Touts Silver’s Bullish Future

Crypto Market Recap: Bitcoin Logs Weakest Monthly Growth in a Year Despite Strong ETF Inflows

Element79 Gold Announces Notice of Force Majeure on Lucero Project

Fill Out & Get More Relevant News

Your name

Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
Categories
- Business (935)
- Investing (2,514)
- Stocks (1,163)
- Uncategorized (20)
- World News (3,041)

Disclaimer: uptradeyourinvesting.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts
About Us
- Privacy Policy
- Terms & Conditions

Copyright © 2025 uptradeyourinvesting.com | All Rights Reserved

Top

Business
World News
Investing
Stocks

Type above and press Enter to search. Press Esc to cancel.